{"id":"https://openalex.org/W2000302853","doi":"https://doi.org/10.1097/01.cad.0000215058.85813.02","title":"Synergistic antimyeloma effects of zoledronate and simvastatin","display_name":"Synergistic antimyeloma effects of zoledronate and simvastatin","publication_year":2006,"publication_date":"2006-06-09","ids":{"openalex":"https://openalex.org/W2000302853","doi":"https://doi.org/10.1097/01.cad.0000215058.85813.02","mag":"2000302853","pmid":"https://pubmed.ncbi.nlm.nih.gov/16917207"},"language":"en","primary_location":{"id":"doi:10.1097/01.cad.0000215058.85813.02","doi":"https://doi.org/10.1097/01.cad.0000215058.85813.02","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cad.0000215058.85813.02","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001664010","display_name":"Ralf Schmidmaier","orcid":"https://orcid.org/0000-0003-3541-3588","observed_orcids":["https://orcid.org/0000-0003-3541-3588"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Ralf Schmidmaier","raw_affiliation_strings":["Department of Medicine Innenstadt, Division of Hematology and Oncology, University Hospital Munich, Munich, Germany. ralf.schmidmaier@med.uni-muenchen.de","Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine Innenstadt, Division of Hematology and Oncology, University Hospital Munich, Munich, Germany. ralf.schmidmaier@med.uni-muenchen.de","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025804894","display_name":"Meral \u015eim\u015fek","orcid":"https://orcid.org/0000-0002-3279-1404","observed_orcids":["https://orcid.org/0000-0002-3279-1404"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Meral Simsek","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Philipp Baumann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp Baumann","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109892401","display_name":"Bertold Emmerich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bertold Emmerich","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110576594","display_name":"Gerold Meinhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerold Meinhardt","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine Innenstadt, University Hospital Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"to R. Schmidmaier, Department of Haematology and Oncology, Medizinische Klinik Innenstadt, Klinikum der Universit\u00e4t M\u00fcnchen, Ziemssenstr. 1, 80336 M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001664010"],"corresponding_institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"],"apc_list":null,"apc_paid":null,"fwci":2.4365,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.89094231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"17","issue":"6","first_page":"621","last_page":"629"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":0.9940000176429749},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/mevalonate-pathway","display_name":"mevalonate pathway","score":0.8399999737739563},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9150000214576721},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.656000018119812},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cell-adhesion-mediated-drug-resistance","display_name":"cell adhesion-mediated drug resistance","score":0.9160000085830688},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.7120000123977661},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7110000252723694},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.8289999961853027},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.9179999828338623}],"concepts":[{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.8853848576545715},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6815599799156189},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6559925079345703},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6274985671043396},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6041991710662842},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5400972366333008},{"id":"https://openalex.org/C2779982574","wikidata":"https://www.wikidata.org/wiki/Q14913010","display_name":"Mevalonate pathway","level":4,"score":0.5246620178222656},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4974103271961212},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4860139489173889},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4576164782047272},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.45691782236099243},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42989420890808105},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.4245319962501526},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3284701108932495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.309772789478302},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20512977242469788},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07526242733001709},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0660521388053894},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.049032509326934814},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077211","descriptor_name":"Zoledronic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017154","descriptor_name":"Stromal Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017154","descriptor_name":"Stromal Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.cad.0000215058.85813.02","doi":"https://doi.org/10.1097/01.cad.0000215058.85813.02","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.cad.0000215058.85813.02","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:16917207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16917207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1932993947","https://openalex.org/W1968784967","https://openalex.org/W1971916741","https://openalex.org/W1982055377","https://openalex.org/W1994414479","https://openalex.org/W2019194429","https://openalex.org/W2020561186","https://openalex.org/W2033294313","https://openalex.org/W2034141221","https://openalex.org/W2040190064","https://openalex.org/W2040367634","https://openalex.org/W2044794329","https://openalex.org/W2045063002","https://openalex.org/W2055949943","https://openalex.org/W2065506234","https://openalex.org/W2066363570","https://openalex.org/W2069123628","https://openalex.org/W2074515486","https://openalex.org/W2076769374","https://openalex.org/W2090669976","https://openalex.org/W2098097319","https://openalex.org/W2105289281","https://openalex.org/W2165317664","https://openalex.org/W2166249402","https://openalex.org/W2188796504","https://openalex.org/W2322800113","https://openalex.org/W2326495145","https://openalex.org/W2356146626","https://openalex.org/W2414240611","https://openalex.org/W6667691630","https://openalex.org/W6686993324","https://openalex.org/W6706210449","https://openalex.org/W6716314515"],"related_works":["https://openalex.org/W2061676404","https://openalex.org/W2054579613","https://openalex.org/W1988940535","https://openalex.org/W2139431083","https://openalex.org/W1790342853","https://openalex.org/W1995794901","https://openalex.org/W2000024591","https://openalex.org/W2564709685","https://openalex.org/W2094211489","https://openalex.org/W7100659784"],"abstract_inverted_index":{"Despite":[0],"advances":[1],"in":[2,30,42,54,68,95],"the":[3,55,109],"treatment":[4],"of":[5,14,59,100,108,119,123],"multiple":[6],"myeloma,":[7],"it":[8],"remains":[9],"an":[10],"incurable":[11],"disease":[12],"because":[13],"primary":[15],"and":[16,25,47,87,114,121,135],"secondary":[17],"drug":[18,103,125],"resistance.":[19,104,126],"Mevalonate":[20],"pathway":[21,111],"inhibitors":[22],"like":[23,74],"bisphosphonates":[24],"statins":[26],"have":[27],"antimyeloma":[28,72,83,139],"activity":[29,84],"vitro":[31],"at":[32,85],"very":[33],"high":[34],"concentrations,":[35,89],"which":[36],"may":[37],"probably":[38],"not":[39,80],"be":[40],"reached":[41],"vivo.":[43],"NCI-H929,":[44],"OPM-2,":[45],"U266":[46],"RPMI-8226":[48],"myeloma":[49,96],"cell":[50],"lines":[51],"were":[52],"treated":[53],"presence":[56],"or":[57,66,76],"absence":[58],"bone":[60],"marrow":[61],"stromal":[62],"cells":[63,97],"with":[64,70,137],"simvastatin":[65,91,115,136],"zoledronate":[67,113,134],"combination":[69],"classical":[71,138],"drugs":[73],"melphalan":[75],"bortezomib.":[77],"Zoledronate":[78],"did":[79],"show":[81],"substantial":[82],"low":[86],"intermediate":[88],"whereas":[90],"potently":[92],"induced":[93],"apoptosis":[94,120],"without":[98],"signs":[99],"primary,":[101],"cell-adhesion-mediated":[102,124],"Furthermore,":[105],"sequential":[106],"blockage":[107],"mevalonate":[110],"by":[112],"demonstrated":[116],"synergistic":[117],"induction":[118],"reversal":[122],"Our":[127],"data":[128],"provide":[129],"a":[130],"rationale":[131],"for":[132],"combining":[133],"drugs.":[140]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}